AI Ophthalmology and Optometry | Altris AI

Altris AI RUO Models for Dry AMD Research

Learn how Altris AI RUO Models support Dry AMD Research & Analysis

Book Intro AI Ophthalmology and Optometry | Altris AI

Altris IMS is an FDA-cleared (510(k)) ophthalmic data-management system, designed to securely import, store, organize, and display OCT imaging data.
Intended for use by eye-care professionals in clinical workflows to manage patient imaging data and generate clinical reports.

Exploration and quantitative characterization of Dry AMD–related OCT imaging features, including confluent drusen, hard drusen, soft drusen, reticular pseudodrusen, RPE atrophy, hypertransmission, neurosensory retinal atrophy, vitelliform material, and chorioretinal scar.

Measurements visualized on ETDRS grids and B-scans for research analysis.

Longitudinal visualization of drusen characteristics, including a dedicated Drusen Count display.

Optional exploratory analytics for research purposes using RUO tools.

Research Use Only. Not for diagnostic procedures.

Platform overview

Only practical features for eye care specialists and clinical research

The security of patients’ data is our top priority: we are GDPR compliant, all data is encrypted, CE-certified, and FDA- cleared (510k).

Alisdair Buchanan Optometry Owner, UK

"Altris IMS has significantly enhanced the way we work with OCT scans."

Jeff Sciberras Optometry Owner

"The introduction of OCT with Altris IMS has transformed my practice literally overnight. The integration was seamless and Altris customer support has been outstanding."

Clara Pereira Optometrist, Portugal

"Altris IMS gives me an extra layer of certainty."

Dr. Sundeep Kheterpal Surgeon

"We are very happy with the outstanding customer service and support."

Dry age-related macular degeneration research USA on how Dry AMD–related imaging features evolve by reviewing quantitative outputs and longitudinal comparisons. Visualization tools allow exploratory analysis of data across multiple images through maps, trend graphs, and percentage-based comparisons.

Efficient exploration of Dry AMD–associated imaging features for research workflows.
Quantitative characterization of biomarkers to support objective, repeatable research analysis.
Longitudinal visualization tools to study changes over time in OCT-derived measurements.
Research-focused review of drusen characteristics, including type, volume, area, and size, using the Drusen Count display.
Reproducible, automated measurements enable structured evaluation of OCT imaging features for research and analytical purposes. Research Use Only. Not for diagnostic procedures.

Add OCT examinations from different visits

Label Dry AMD biomarkers with color-coding

Explore the area and volume of biomarkers

Compare how Dry AMD changes in progression

How Altris Works?

And how it supports the research and analysis of Dry AMD–related imaging features?

Altris AI is a web-based platform developed with input from retina specialists to support eye-care professionals in reviewing and analyzing OCT imaging data.

Using a large repository of OCT scans with expert graphical annotations, the Altris AI Research Use Only (RUO) models are designed to:

Identify and characterize retinal imaging features and biomarkers, including those associated with Dry AMD, for research purposes only

Provide quantitative outputs to support consistent evaluation of OCT data across multiple studies

Enable longitudinal analysis of imaging features to study how they change over time in research workflows

Support research interpretation through objective, reproducible measurements and structured visualization tools

AI components are for Research Use Only. Not for diagnostic or therapeutic purposes.

Formats

DICOM format will help you to extract maximum information. However, the system works with all data formats, such as jpg, and png

OCT equipment

Altris tool is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Pharma

For innovative approach in pharma

What you get:

Centralized OCT Data Management
Historical Data Analysis
Vendor-neutral analysis of OCT scans (8 manufacturers)
Data Security & Compliance
Additional capabilities for research
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.
Reports

For Eye Care

IMS for Ophthalmology and Optometry

What you get:

Centralized OCT Data Management
Vendor-Neutral OCT Compatibility (8 manufacturers)
Historical OCT Data Analysis
Seamless Clinical Workflow Integration
Informative OCT reports
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.

Contact us

Ask us any question

Book intro + free trial

Demo